Literature DB >> 12825831

Caffeine analogs: effects on ryanodine-sensitive calcium-release channels and GABAA receptors.

Dan Shi1, William L Padgett, John W Daly.   

Abstract

1. Caffeine at 0.3-10 mM enhanced the binding of [3H]ryanodine to calcium-release channels of rabbit muscle sarcoplasmic reticulum. A variety of other xanthines were as efficacious as caffeine or nearly so, but none appeared markedly more potent. 2. Caffeine at 1 mM markedly inhibited binding of [3H]diazepam to GABAA receptors in rat cerebral cortical membranes. 3. Other xanthines also inhibited binding with certain dimethylpropargylxanthines being nearly fivefold more potent than caffeine. 4. Caffeine at 1 mM stimulated binding of [35S]TBPS to GABAA receptors as did certain other xanthines. 5. The dimethylpropargylxanthines had little effect. 1,3-Dipropyl-8-cyclopentylxanthine at 100 microM had no effect on [3H]diazepam binding, but markedly inhibited [35S]TBPS binding. 6. Structure-activity relationships for xanthines do differ for calcium-release channels and and for different sites on GABAA receptors, but no highly selective lead compounds were identified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12825831     DOI: 10.1023/a:1023688604792

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  53 in total

1.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

2.  Voltage-dependent suppression of calcium current by caffeine in single smooth muscle cells of the guinea-pig urinary bladder.

Authors:  M Yoshino; Y Matsufuji; H Yabu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

3.  Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.

Authors:  D Ukena; C Schudt; G W Sybrecht
Journal:  Biochem Pharmacol       Date:  1993-02-24       Impact factor: 5.858

4.  Characterization and differential regulation of GABAA and benzodiazepine receptors in rat neocortex.

Authors:  C Shaw; B A Scarth
Journal:  Brain Res Mol Brain Res       Date:  1991-10

5.  Caffeine interaction with fluorescent calcium indicator dyes.

Authors:  M Muschol; B R Dasgupta; B M Salzberg
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

6.  Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds.

Authors:  E Rousseau; J Ladine; Q Y Liu; G Meissner
Journal:  Arch Biochem Biophys       Date:  1988-11-15       Impact factor: 4.013

7.  The effects of caffeine on ATP-sensitive K(+) channels in smooth muscle cells from pig urethra.

Authors:  N Teramoto; T Yunoki; K Tanaka; M Takano; I Masaki; Y Yonemitsu; K Sueishi; Y Ito
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

8.  A novel Ca2+ entry mechanism is turned on during growth arrest induced by Ca2+ pool depletion.

Authors:  C A Ufret-Vincenty; A D Short; A Alfonso; D L Gill
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

9.  The calcium-ryanodine receptor complex of skeletal and cardiac muscle.

Authors:  I N Pessah; A L Waterhouse; J E Casida
Journal:  Biochem Biophys Res Commun       Date:  1985-04-16       Impact factor: 3.575

Review 10.  Second messenger systems as targets for new therapeutic agents: focus on selective phosphodiesterase inhibitors.

Authors:  J M Palacios; J Beleta; V Segarra
Journal:  Farmaco       Date:  1995-12
View more
  10 in total

1.  Life-threatening hypokalaemia and lactate accumulation after autointoxication with Stacker 2, a 'powerful slimming agent'.

Authors:  L R H de Wijkerslooth; B C P Koch; M M Malingré; P Smits; A K M Bartelink
Journal:  Br J Clin Pharmacol       Date:  2008-09-23       Impact factor: 4.335

2.  Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants.

Authors:  Raul Chavez Valdez; Rajni Ahlawat; Marsha Wills-Karp; Amy Nathan; Tarrah Ezell; Estelle B Gauda
Journal:  J Pediatr       Date:  2010-08-06       Impact factor: 4.406

3.  Contribution of transient receptor potential channels to the control of GABA release from dendrites.

Authors:  Thomas Munsch; Marc Freichel; Veit Flockerzi; Hans-Christian Pape
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

Review 4.  The Taste of Caffeine.

Authors:  Rachel L Poole; Michael G Tordoff
Journal:  J Caffeine Res       Date:  2017-06-01

5.  Winning a won game: caffeine panacea for obesity syndemic.

Authors:  M Myslobodsky; A Eldan
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

6.  Direct conversion of theophylline to 3-methylxanthine by metabolically engineered E. coli.

Authors:  Khalid H R Algharrawi; Ryan M Summers; Sridhar Gopishetty; Mani Subramanian
Journal:  Microb Cell Fact       Date:  2015-12-21       Impact factor: 5.328

Review 7.  Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson's Disease.

Authors:  Giovanni Schepici; Serena Silvestro; Placido Bramanti; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2020-07-04       Impact factor: 5.923

Review 8.  The Aging GABAergic System and Its Nutritional Support.

Authors:  Demetra J Mills
Journal:  J Nutr Metab       Date:  2021-04-25

9.  Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia.

Authors:  Martina Di Rocco; Serena Galosi; Enrico Lanza; Federica Tosato; Davide Caprini; Viola Folli; Jennifer Friedman; Gianfranco Bocchinfuso; Alberto Martire; Elia Di Schiavi; Vincenzo Leuzzi; Simone Martinelli
Journal:  Hum Mol Genet       Date:  2022-03-21       Impact factor: 6.150

10.  Caffeine-Induced Suppression of GABAergic Inhibition and Calcium-Independent Metaplasticity.

Authors:  Masako Isokawa
Journal:  Neural Plast       Date:  2016-01-14       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.